SkinBioTherapeutics plc (AIM:SBTX)

Revenue by Product

Financials in millions GBX. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Human Microbiome Research	1.21M	Log In	Log In
Human Microbiome Research Growth	815.26%	Log In	Log In

Revenue by Geography

Financials in millions GBX. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
United Kingdom	990.35K	Log In	Log In
United Kingdom Growth	732.78%	Log In	Log In
European Union	102.68K	Log In	Log In
European Union Growth	2559.31%	Log In	Log In
Rest of World	80.28K	Log In	Log In
United States	35.36K	Log In	Log In
United States Growth	281.27%	Log In	Log In